XENE stock forecast
Our latest prediction for Xenon Pharmaceuticals, Inc.'s stock price was made on the Aug. 15, 2017 when the stock price was at 2.45$.
In the short term (2weeks), XENE's stock price should outperform the market by 6.35%. During that period the price should oscillate between -8.95% and +18.83%.
In the medium term (3months), XENE's stock price should outperform the market by 9.76%. During that period the price should oscillate between -18.25% and +45.94%.Get email alerts
Create a solid portfolio with XENE
About Xenon Pharmaceuticals, Inc.
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
At the moment the company generates 14M USD in revenues.
On its last earning announcement, the company reported a loss of -1.34$ per share.
The book value per share is 1.40$
Three months stock forecastAug. 15, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|